Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach
- PMID: 9566814
- DOI: 10.1007/s002130050567
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach
Abstract
The effects on behaviour of the putative selective D3 dopamine receptor antagonists GR 103691, nafadotride and U 99194A were compared with those of the generic D2-like antagonist haloperidol, using an ethologically based approach. Neither GR 103691 (0.008-1.0 mg/kg) nor nafadotride (0.025-1.6 mg/kg) influenced any element of behaviour. Conversely, U99194A (1.67-45 mg/kg) effected a dose-dependent stimulation of episodes of non-stereotyped sniffing, locomotion, chewing and eating, with some stimulation of rearing, and reduced baseline levels of grooming; thereafter, as sniffing and locomotion declined, stimulation of episodes of grooming emerged. Haloperidol (0.0008-0.1 mg/kg) failed to promote any element of behaviour and reduced baseline levels of grooming; responsivity to U99194A was antagonised by pretreatment with haloperidol. The lack of effect of GR 103691 (> 100-fold D3/D2 selectivity) and nafadotride (10-fold D3/D2 preference), in contrast to the characteristic "ethogram" for U99194A (25-fold D3/D2 selectivity), indicated a fundamental difference in their mechanisms of action. This topography of responsivity to U99194A overlapped somewhat with the profiles of both D2-like and D1-like agonists, and its sensitivity to antagonism by haloperidol also indicated a dopaminergic basis thereto. However, differences among GR 103691, nafadotride and U99194A bore no relation to their relative selectivities for the D3 receptor, and the basis thereof remains unclear. Theorising as to the behavioural role of the D3 receptor may need to be tempered pending the identification of a range of chemically distinct D3 antagonists of higher selectivity.
Similar articles
-
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.J Pharmacol Exp Ther. 1998 Oct;287(1):187-97. J Pharmacol Exp Ther. 1998. PMID: 9765337
-
Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.Behav Pharmacol. 2002 Dec;13(8):633-8. doi: 10.1097/00008877-200212000-00004. Behav Pharmacol. 2002. PMID: 12478213
-
Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.Behav Pharmacol. 2004 Jul;15(4):253-62. doi: 10.1097/01.fbp.0000137857.26150.ab. Behav Pharmacol. 2004. PMID: 15252275
-
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches.Eur Neuropsychopharmacol. 1995;5 Suppl:3-9. doi: 10.1016/0924-977x(95)00030-s. Eur Neuropsychopharmacol. 1995. PMID: 8775753 Review.
-
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.Front Neurosci. 2016 Oct 5;10:451. doi: 10.3389/fnins.2016.00451. eCollection 2016. Front Neurosci. 2016. PMID: 27761108 Free PMC article. Review.
Cited by
-
The role of the dopamine D1 receptor in social cognition: studies using a novel genetic rat model.Dis Model Mech. 2016 Oct 1;9(10):1147-1158. doi: 10.1242/dmm.024752. Epub 2016 May 19. Dis Model Mech. 2016. PMID: 27483345 Free PMC article.
-
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.J Neurosci. 2000 Sep 1;20(17):6431-41. doi: 10.1523/JNEUROSCI.20-17-06431.2000. J Neurosci. 2000. PMID: 10964949 Free PMC article.
-
Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.Psychopharmacology (Berl). 2003 Aug;169(1):28-34. doi: 10.1007/s00213-003-1466-2. Epub 2003 Jun 27. Psychopharmacology (Berl). 2003. PMID: 12830366
-
Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.Psychopharmacology (Berl). 2015 Jul;232(13):2377-91. doi: 10.1007/s00213-015-3872-7. Epub 2015 Feb 3. Psychopharmacology (Berl). 2015. PMID: 25647696
-
Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA.Biomolecules. 2019 Sep 20;9(10):511. doi: 10.3390/biom9100511. Biomolecules. 2019. PMID: 31547016 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources